PrimeVigilance is pleased to announce that both Dr. Forstner (PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology) and Dr. Petracek (PrimeVigilance CEO, and former Head of Risk Management at EMA) were selected expert speakers during the upcoming DIA PVRMS conference held January 28-30 in Washington, DC.

On Monday 28th January, Dr. Petracek will be on the panel for Session 5: Pharmacovigilance and Risk Management Challenges in Advanced Therapeutics, with his topic being “Benefit-Risk Management of Recently Authorized ATMPs in the EU – Lessons Learned”.

On Tuesday 29th January, Session 8, Dr. Forstner will deliver a focused presentation “The European IV Iron PASS Consortium: Experiences from coordinating a multi-company, multi-registry PASS”.

DIA’s Pharmacovigilance and Risk Management Strategies Conference provides the context, background, updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies.

Program and registration details are available on the #DIAwebsite here

If you would like to set up a meeting with us during this event or have any other questions, please let us know by contacting us directly at

Share this:




This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services